eMDI for Patients with Asthma and COPD

H&T Presspart and Cohero Health are currently collaborating with pharmaceutical manufacturers who are leveraging the technology for pipeline development and value-added product differentiation. As a fully functioning, market-ready device, it will enable pharmaceutical manufacturers the best possible care to patients with asthma and COPD quickly and in a cost-effective manner. Download this free whitepaper to find out more.

More About This Company

About the eMDI

H&T Presspart and Cohero Health are currently collaborating with pharmaceutical manufacturers who are leveraging the...